The same research group [2] further examined the fate of latex microspheres injected into the skin and noticed that by 18 h after injection most microspheres were phagocytosed. Of note, a large population of cells containing FITC-latex accumulated in the draining lymph nodes (LNs), mainly in the T-cell area. These cells phenotypically resembled DCs and were absent from monocyte-deficient op/op mice. These observations suggested that

a subset of monocyte-derived DCs could play a major role in PFT�� purchase presentation of particulate antigens and were reminiscent of old studies showing that DCs could be obtained in culture from human PBMCs [3, 4]. Although the precursors were not formally identified, they were plentiful in human blood and adherent, suggesting a monocytic lineage. More recently, Geissmann and colleagues [5] examined blood monocytes in mice and humans and identified two functional subsets as defined by the level of expression of CX3CR1. Resident CX3CR1high monocytes were found in the blood and noninflamed peripheral organs where they homed in a CX3CR1-dependent way. CX3CR1low monocytes were short-lived, were actively recruited to inflamed tissues independently of their CX3CR1 genotype, and differentiated into functional DCs that had the ability to stimulate naive T cells. Although the authors proposed

the term “inflammatory monocytes” for the immediate precursors Masitinib (AB1010) of antigen-presenting DCs, we will name them “inflammatory DCs,” unless discussing monocyte differentiation to DCs, as subsequent reports clearly indicate that most “inflammatory monocytes” selleck differentiate into CD11c+ cells displaying functional properties of the dendritic family. Other identified inflammatory monocytes such as Ly6Chigh or CCR2+ monocytes are discussed later in this review in the sections Th2-type immunity and Th1-type immunity. These observations

identified a novel population of DCs, which do not derive from a MDP (macrophage/DC precursor)/CDP (common DC progenitor) as shown for so-called classical DCs such as conventional and plasmacytoid DCs, but rather from monocytes in inflammatory conditions (Fig. 1). This raises the question of the respective role of conventional versus inflammatory DCs in innate and adaptive immune responses. The observation that monocytes may, in some conditions, differentiate into DCs was confirmed by Serbina et al. [6], in a study published back-to-back with that of Geissmann and colleagues [5]. In the course of the study by Serbina et al. [6], which aimed to identify the source of nitric oxide (NO) and tumor necrosis factor (TNF) (essential mediators produced by monocytes and DCs for the control of Listeria monocytogenes), the authors showed that infection with this bacteria induced the recruitment of a novel TNF- and iNOS-producing DC subset to the spleen.

For the NO and cytokine assay, approximately 3 × 105 RAW 264·7 or J774·1 macrophages were seeded in a 96-well culture plate (BD, Falcon, San Jose, CA). Cells were stimulated with different concentrations of rRv2626c and incubated at 37° for 48 hr. The positive control group received LPS (1 μg/ml) and IFN-γ (1 ng/ml). As and when required, cells were pretreated PLX-4720 in vitro by adding 10 μm pyrrolidine dithiocarbamate (PDTC; Sigma) and incubating for 1 hr, followed by stimulation with various concentrations of rRv2626c. For NO estimation by the Griess assay, equal aliquots of the culture supernatants were dispensed in duplicate into a 96-well culture plate and

mixed with an equal volume of Griess reagent,35 composed of 1% [weight/volume (w/v)] sulphanilamide, 0·1% (w/v) napthyl-ethylenediamine hydrochloride and 2·5% (v/v) H3PO4. After incubation at room temperature for 5 min, the absorbance was measured at 540 nm in an Ultra Microplate Reader (Bio-Tek, Winooski, VT). The concentration of nitrate was interpolated from the NaNO2 standard curve. TNF-α and IL-12 p40 levels in the culture supernatants were measured by enzyme immunoassay (EIA) (BD Biosciences Pharmingen, San Diego, CA) as described

previously.36 Standard curves for each cytokine were obtained using the recombinant standard protein provided by the manufacturer. RAW 264·7 macrophages (2 × 106 cells/well in a six-well culture plate) were left untreated or treated with 3 μg/ml of rRv2626c in the absence or Lumacaftor order Vitamin B12 presence of LPS and IFN-γ. After 24 hr of incubation, cells were harvested and washed three times with ice-cold FACS buffer [PBS containing 1% bovine serum albumin (BSA) and 0·01%

sodium azide] and then re-suspended in FACS buffer and incubated with anti-mouse B7-1 (clone 1G10; BD Biosciences Pharmingen), anti-mouse B7-2 (clone GL1; BD Biosciences Pharmingen) and anti-mouse CD40 (clone 3/23; BD Biosciences Pharmingen). The control group received isotype control antibody. Cells were washed again with FACS buffer and incubated with anti-mouse FITC (Sigma-Aldrich). Flow cytometric analysis was performed (Becton Dickinson, San Jose, CA) and the FACS data were recorded for 20 000 events for each labelled cell population. Flow cytometry data analyses were carried out using cell quest data analysis software (BD Biosciences, San Jose, CA). The RAW 264·7 macrophages were seeded at a density of 5 × 106 per well in a six-well culture plate and were either left untreated or pretreated with PDTC for 1 hr followed by stimulation with either 5 μg of rRv2626c or a combination of LPS and ΙFN-γ. Cells were harvested and the whole-cell extract was prepared as described previously.

For the in vitro suppression assay, CD4+ T cells from untreated Tg4 mice were stimulated either alone or in the presence of a titrated number of CD4+

T cells from i.n. Ac1–9[4K]-, [4A]- or [4Y]-treated Tg4 mice that had been re-stimulated in vitro in order to maximize IL-10 secretion 12. As shown in Fig. 5A, T cells from untreated mice proliferated optimally in response to Ac1–9[4K] stimulation, whereas CD4+ T cells from i.n. Ac1–9[4K]-, [4A]- or [4Y]-treated Tg4 mice responded poorly. When co-cultured with Venetoclax CD4+ T cells from untreated mice at a 1:1 ratio, CD4+ T cells from Tg4 mice treated with i.n. Ac1–9[4A] or [4Y] appeared suppressive, inhibiting naïve CD4+ T-cell proliferation by 55 and 64% at a ratio of 1:1, titrating out to 1:2 and 1:4, respectively (Fig. 5A). Supernatants from the in vitro suppression assays were collected and analyzed for IL-2 levels by sandwich ELISA. As shown in Fig. 5B, CD4+ T cells from all three peptide-treated groups produced

very small amounts of IL-2 when compared with untreated CD4+ T cells. The amount of IL-2 detected in the co-cultures reflected the amount of suppression observed in Fig. 5A. Taken together, these results demonstrate a hierarchy in the ability of the tolerizing find more peptides to induce Treg as significant suppression of T-cell proliferation and IL-2 secretion was only detected in co-cultures containing CD4+ T cells from i.n. Ac1–9 [4A]- and [4Y]-treated Tg4 mice. An in vivo model of T-cell-mediated suppression has been described previously 6 whereby CFSE-labeled Tg4 cells were transferred into either untreated or peptide-treated recipient mice and their proliferation to subsequent peptide challenge assessed by CFSE dilution. This assay was used here to address the capacity of the different affinity

peptides to mediate suppression in vivo. Figure 6 shows the proliferation of naïve Tg4 CD4+ T cells adoptively transferred to untreated or peptide-treated recipient mice. The baseline CFSE level was determined by administering a single dose of i.n. PBS to untreated recipient mice. Upon challenge with Ac1–9[4A], CFSE+CD4+ T cells divided in the untreated recipient mice with a division Abiraterone manufacturer index of 0.32. The division index of CFSE+CD4+ T cells transferred to i.n. Ac1–9[4K]-treated recipients was lower (0.28) but not significantly different from the above. However, when transferred to i.n. Ac1–9[4A]- or [4Y]-treated recipient mice, the division index of the same cells was only 0.13 and 0.06, respectively. Thus, the proliferation of transferred T cells was significantly suppressed upon transfer to i.n. Ac1–9[4A]- and [4Y]-treated recipient mice. These results are consistent with those depicted in Fig. 5 and demonstrate that the observed hierarchy in the ability of the tolerizing peptides to induce Treg and thus mediate suppression extends to in vivo suppression of T-cell proliferation.

8  daltons. Because these two values are similar, we consider that

the purified protein is the product of the gene whose nucleotide sequence was determined in this experiment. The lipase of A. sobria is biosynthesized Selleck CX-4945 as a precursor form consisting of a pre-region (from the first to 18th amino acid residue) and mature region (from the 19th amino acid residue to the carboxy terminal end). The pre-region functions as a signal peptide in translocation across the inner membrane and is cleaved off during translocation. As shown in Figure 1, we confirmed that the mature form of the lipase exists in the culture supernatant; however, there is a possibility that the majority of lipase remains in cells, some lipase appearing outside the cells due to cell destruction. To examine the location of the lipase, the cells were cultured in NB (0.5). At 6, 12, and 24  hrs, a portion of the culture fluid (20  mL) was removed. Three fractions, the culture supernatant, periplasmic, and outer membrane

fractions, were made from each culture and the existence of lipase in each fraction was examined by immunoblotting. As shown in Figure 7, lipase was detected in the periplasm and culture supernatant fractions. In particular, the density of the band in lane 9 (sample prepared from the culture supernatant fraction after Galunisertib concentration 24  hr culture) is high. This band was not detected in any samples prepared from the outer membrane fraction throughout the cultivation period, indicating that the lipase is an exoprotein. Because the lipase synthesized

in the cytoplasm translocated across the inner membrane with the help of the pre-region and remained for a while in the periplasm, samples prepared IKBKE from the periplasmic fraction reacted with the antiserum (Fig. 7) and the lipase crossed the outer membrane without remaining in it. As shown in Figure 1, production of lipase was suppressed when A. sobria 288 (asp−, amp−) was cultured in NB (3.0). To elucidate how NaCl suppressed lipase production, we examined the effect of NaCl in medium on gene transcription by A. sobria for the lipase. A. sobria 288 (asp−, amp−) were cultured in NB (0.5) and NB (3.0) and the cells recovered 3, 6, 9, 12, and 24  hrs after initiation of the culture. The RNAs of these cells were extracted and the amounts of RNA indicated in Figure 8 fixed to the membrane and reacted with the probe for the lipase gene. As shown in Figure 8, the densities of the dots in the samples from the culture in NB (3.0) at 3, 6, and 9  hrs were slightly higher than those from culture of the strain in NB (0.5). Next, we examined the transcriptional level of lipase gene by quantitative RT-PCR. The cDNAs were prepared from the RNA samples obtained from the cells cultured in NB (0.5) and NB (3.0) for 6  hrs by treatment with reverse transcriptase. The DNA fragment of lipase was amplified from these cDNAs. However, amplification did not occur in the sample which was not treated with reverse transcriptase.

The differentiating GDC-0973 nmr step between synthesis of chondroitin suphate and dermatan sulphate GAGs is the epimerization of GlcA to its stereoisomer iduronic acid, whereby the presence of iduronic acid confers synthesis of dermatan sulphate. If alternatively spliced variants of a protein possess GAG initiation sites, they may be referred to as ‘part-time’ proteoglycans [43]. GAG chains are additionally variably sulphated by sulpherotransferase enzymes. CSPGs will be

described in more detail due to their particular relevance to CNS plasticity and repair. CSPGs are a well-studied family of CNS ECM molecules. They are known to play an important role in preventing nerve growth and restricting plasticity following CNS injury and, as such, have been widely targeted in experimental strategies to promote repair in a number of experimental models [44–46]. Members of the CSPG family that are implicated in the response to CNS injury include the lecticans, NG2, phosphacan and the small leucine-rich proteoglycans decorin and biglycan. CS-GAG chains are sulphated at particular residues to form distinct motifs (see Figure 1B). In mammals GalNAc may be mono- or disulphated at C4 and/or C6 to produce chondroitin sulphate-A

see more (CS-A; GlcA-4SGalNAc), chondroitin sulphate-C (CS-C; GlcA-6SGalNAc) and chondroitin sulphate-E (CS-E; GlcA-4S,6SGalNAc) or disulphated at C2 of GlcA and C6 of GalNAc to produce chondroitin sulphate-D (CS-D; GlcA-2S, 6SGalNAc). Chondroitn sulphate-B (CS-B) is dermatan sulphate [47,48]. Sulphation motifs bestow distinct interactive properties upon CSPGs and within PNNs, for example CS-E is specifically thought to provide an attachment site for the guidance cue semaphorin 3A [49,50]. The lecticans Selleckchem Baf-A1 (also known as hyalectan) are the most abundant family of CSPGs within the CNS, comprising aggrecan, versican, neurocan and brevican. Lectican core proteins range in size from 145 kDa to over 300 kDa. They all possess an N-terminal G1 domain and C-terminal G3 domain (see Figure 1C). The G1 domain contains a HA-binding region and immunoglobulin-like

loop, interacting with HA and link protein to form stable ternary complexes in the ECM. The G3 domain comprises EGF repeats (both an EGF module and a calcium-binding EGF module), a C-type lectin domain (CLD) and a complement binding protein-like motif. The CLD has conserved expression across all lecticans and is involved in mediating interactions with other matrix components. This includes ligands with multimeric affinity to CLD such as tenascins, thus thought to enable assembly of cross-linked matrices [51]. Affinity of such interactions may also be regulated by alternative splicing of other G3 domains [52]. Aggrecan additionally includes a G2 domain which is of similar composition to the tandem repeats within G1, but not thought to impart additional interaction with HA [53,54].

We next examined the mannan structure of CMWS and compared it to that of CAWS, because we have previously found that the mannan moiety might be responsible for these activities (9–15), and many reports have indicated that Candida cell wall mannan contributes to its antigenicity and pathogenicity (30). In addition, the structure of

mannan from Candida differs between species (21, 31–35) and can also be altered by environmental conditions such as growth temperature (18), pH (19), and osmotic pressure (20). As revealed by the reactivity of Candida serum factors (Table 3), CMWS reacted to antisera against α-mannan but not β-mannan. Moreover, NMR analysis of CMWS confirmed that CMWS contains only α-mannosyl, Saracatinib cost and not β-mannosyl, residues. These serum reactivity and NMR data are similar to those of CAWS. These results strongly indicate that α-mannan, but not β-mannan, contributes to these pathogenic

effects of Tanespimycin ic50 CMWS. Numerous studies on the antigenicity and pathogenicity of fungal cell wall mannans, especially those from C. albicans and Saccharomyces cerevisiae, have been reported. Kind et al. reported that the lethal toxicity and increased vascular permeability of some yeast mannans, including that of C. albicans, seem to depend on the 1,2-α-, 1,6-α-linkage in their main chain (30). Garner et al. reported that tumor necrosis factor-α is produced in vivo in response to mannan derived from C. albicans (36). These effects can be regulated by mannan ligands such as anti-mannan antibodies and corticosteroids. On the other hand, numerous studies have shown that 1,2-β-linked mannans, which are only expressed by pathogenic yeasts such as C. albicans, are vital for cell adhesion to host cells (27) and cytokine MycoClean Mycoplasma Removal Kit production from various cells (37). This specific glycan does not bind

to typical mannan receptors such as the macrophage mannose receptor or mannose-binding lectin. However, some studies have recently reported that galectin-3 is the receptor for 1,2-β-linked mannan (38), and may contribute to some biological effects of mannan (39). In our studies, CAWS, an extracellular polysaccharide fraction obtained from the culture supernatant of C. albicans, has been found to induce coronary arteritis and acute anaphylactoid shock (10–17). These biological effects depend on the pH of the culture process (15). CAWS synthesized in neutral pH conditions that result in the expression of 1,2-β-mannosyl residues produces significantly reduced acute anaphylactoid shock, coronary arteritis, and complement activation. This pattern was most definitely matched by the results of investigations of the activities of mannan from C. albicans cell wall (9). Our previous studies have clearly suggested that the β-mannosyl residue attached to nonreducing terminal α-mannosyl branched chains within an acid-stable region is very different in biologically active versus inactive mannan (9, 15).

The recognition of a patient with DBA who subsequently developed CVID lends support to our previous finding of a heterozygous mutation in the SBDS gene of SBDS in another CVID patient, suggesting that ribosome biogenesis defects are responsible for a subset of CVID. Genetic defects in the ribosomal translational machinery responsible for various bone marrow failure syndromes are recognized readily when they manifest in children, but diagnosing these in adults presenting with complex phenotypes and hypogammaglobulinaemia can be a challenge. In this perspective paper, we discuss our clinical experience in CVID patients with ribosomopathies, and

review the immunological abnormalities GSI-IX in other conditions associated with ribosomal

dysfunction. With genetic testing available for various bone marrow failure syndromes, our hypothesis that ribosomal abnormalities may be present in patients with CVID could be proved in future studies by testing for mutations in specific ribosomal genes. New knowledge might then be translated into novel therapeutic strategies for patients in this group of immunodeficiency disorders. Common variable immunodeficiency disorders (CVID) comprise a range of hypogammaglobulinaemias, for which a small number of genetic defects have been identified [1–3]. However, these account for only a small proportion of cases of CVID, and the majority of patients have no identified genetic cause. A number of bone marrow failure syndromes are now recognized to be due to defects in ribosome biogenesis with mutations in genes coding for ribosomal proteins. Various immunological abnormalities find more are evident in these syndromes and old provide proof that failure of optimal ribosome function, ‘ribosomopathies’, can also affect cells of the immune system. These syndromes are heterogeneous in their clinical presentations: for example, patients with Shwachman–Diamond syndrome (SDS) with confirmed mutations in the SBDS gene (Chr7q11) may not have all the characteristic features of neutropenia, skeletal defects and pancreatic insufficiency [4]. There is emerging evidence

that loss of Shwachman–Bodian–Diamond syndrome (SBDS) protein affects haematopoeisis and numbers of circulating B lymphocytes [5]. Craniofacial malformation syndromes such as Treacher–Collins syndrome, caused by haploinsufficiency of the treacle protein, also affect the cells of the immune system [6], and a broader immunological defect has been described in the congenital anaemia of Diamond–Blackfan syndrome (Diamond–Blackfan anaemia: DBA) [7]. The 5q- syndrome, a somatically acquired deletion of chromosome 5q and a subtype of myelodysplastic syndrome, leads to haploinsufficiency of a ribosomal protein that is also implicated in DBA. The active eukaryotic ribosome, the site of protein synthesis, is composed of 40S and 60S subunits.

11 Subsequent experiments, involving TG and TT only, were performed in RPMI-1640 medium (Gibco BRL, Life Technologies, Taastrup, DK) containing penicillin/streptomycin and supplemented with l-glutamine (2 mm). All culture experiments were performed in the presence of 30% autologous serum. 5-Carboxy-2′,

7′-dichlorofluorescein diacetate succinimidyl ester (CFSE) (Molecular Probes, Eugene, OR), kept as a stock solution of 5 mm in dimethylsulphoxide, was diluted to 50 μm in α-MEM before use. The CFSE was added to suspensions of PBMC in α-MEM to a final concentration of 2 μm. The cells were incubated with CFSE for 10 min in a humidified incubator at 37°, 5% CO2. Flow cytometry was performed using BD Biosciences FACScan or FACSCalibur flow cytometers with argon laser KU-60019 excitation (488 nm) and the data were analysed using CellQuest software. The signals from CFSE and PerCP-anti-CD4 (or anti-CD14) were detected buy SCH 900776 in channels FL1 and FL3, respectively. CD4+ T cells, or monocytes, were identified using a combination of forward scatter versus side scatter gating and the appropriate PerCP-conjugated marker. In all measurements, the background proliferation was subtracted from the proportion of dividing cells

upon antigen stimulation. The CFSE-labelled PBMC were distributed in 96-well culture plates (5 × 105 cells/well) and incubated with TT (10 μg/ml), TG (30 μg/ml), KLH (30 μg/ml) or without antigen in α-MEM containing 30% autologous serum (total volume = 200 μl). Following culture in a humidified incubator Fossariinae at 37°, 5% CO2 for 1, 5, 7 or 9 days, the supernatants were harvested for cytokine analysis and the cells were washed in PBS (4 ml) and stained with

PerCP-anti-CD4 for assessment of CD4+ T-cell proliferation by flow cytometry. Proliferation was expressed as % dividing cells, determined as 100 × (no. of CD4+ T cells displaying CFSE fluorescence < 50% the fluorescence signal for non-dividing cells)/(total no. of CD4+ T cells). The content of IL-2, IFN-γ, IL-4, IL-5, TNF-α and IL-10 in culture supernatants at days 1, 5, 7 and 9 was quantified by means of a Th1/Th2 Cytometric Bead Array kit using a FACSCalibur flow cytometer. Data analysis was performed using the Cytometric Bead Array software (BD Biosciences). Interleukin-10 secretion by individual cells was examined with a cytokine capture assay using anti-IL-10 and anti-CD45 co-conjugated beads (MACS Miltenyi, Biotech Line AS, Slangerup, Denmark). Lymphoprep-purified PBMC were suspended at a density of 106 cells/ml in RPMI-1640 with 30% autologous serum and challenged with TG (30 μg/ml), TT (10 μg/ml) or no antigen over night at 37°. The IL-10 secretion assay was performed, without erythrolysis, according to the manufacturer’s protocol.

Of the 148 live donors, 24 were hypertensive (ABPM > 135/85 mmHg and clinic BP > 140/90 mmHg) before donation. The group concluded that patients with moderate, essential hypertension and normal kidney function have no adverse outcomes with respect selleck screening library to BP, renal function or urinary protein excretion in the first year after living kidney donation. Young et al. performed a systematic review and meta-analysis and identified six studies

on 125 hypertensive donors (Fig. 2).30 A number of methodological issues restrict the external validity of all of these studies. Follow up was for a median of 2.6 years, with two having a mean follow up of over 5 years. One study described a 14 µmol/L greater rise in serum creatinine in hypertensive donors compared with donors who were normotensive pre-donation. Two studies described conflicting results on the change in renal function using radioisotope or inulin GFR between 62 hypertensive donors and 527 normotensive donors. One study demonstrated that BP in hypertensive donors at 1 year decreased by 5 mmHg systolic and 6 mmHg diastolic compared with normotensive donors. An additional study found that mean arterial BP following donation decreased

more often in hypertensive donors. Please refer to Table 1– Characteristics of included studies (Appendices). There is a lack of prospective controlled long-term data regarding the effects of nephrectomy in both normal and hypertensive donors. More precise information Aurora Kinase is required and this would ideally be collected prospectively using a live donor registry. On the basis of limited studies, nephrectomy appears to lead to a small increase in BP but there is no evidence of an increased risk HER2 inhibitor of developing hypertension. However, to better assess whether there is an alteration in the risk of developing hypertension, it is acknowledged that prospective

studies of age- and sex-matched individuals with and without nephrectomy would need to be performed. The recommendation to exclude from donation individuals with poorly controlled hypertension or with known hypertensive end-organ damage (e.g. retinopathy, left ventricular hypertrophy, stroke, proteinuria and renal impairment) is based on the known natural history of these disorders. No study has been performed comparing the outcome in these subjects who donate, compared with those who do not. British Transplant Society/British Renal Association: An extensive, 100-page document has been produced outlining similar issues to those discussed here.31 The full version of these British Live Donor Guidelines is available at: http://www.bts.org.uk/transplantation/standards-and-guidelines/ Prospective donors should not be precluded from further evaluation if their office (casual) BP recordings are below 140/90 mmHg. The Amsterdam Forum: A short manuscript outlining similar issues to those discussed here.32 Hypertension has been considered to be a contraindication in potential renal transplant donors.

5A), microvillar

extensions (Fig. 5C) and, for SEMA6A only, motility in T cells (Fig. 6A). Interestingly, SEMA-mediated cytoskeletal interference did not affect the overall β1-integrin-stimulated front-rear polarization or receptor-segregation (Fig. 5B and C) thereby essentially differing from actin cytoskeletal Roscovitine paralysis induced on MV exposure of these cells 18, 47. In line with hypothesis, induction of ceramides as found relevant for MV actin interference 18 was not detectable on SEMA3A/6A exposure of T cells (not shown) indicating the SEMA-induced signalling may not involve SMase activation. In addition to adding to the current view on the role and regulation of human SEMA receptors in the IS in general (such as plexA1 IS recruitment and its importance for IS function in T cells, plexA4 expression in human T cells, plexA1/NP-1 turnover in maturing DC, SEMA3A and SEMA6A in regulation of T-cell protrusions and chemokinetic migration), our study to the best of our knowledge is the first to address regulation of those by a pathogen and their importance in the established MV interference with IS function. Recruitment to and concentration of SEMA receptors

to the IS might, however, also be of relevance for viral transmission there as indicated by the function of NP-1 as physical and functional partners of HTLV env proteins during transmission in the virological synapse 32, 52. Primary human cells were obtained from the Department of Transfusion Medicine, University of Würzburg, LEE011 nmr and analyzed anonymized. All experiments involving human material were conducted according to the principles expressed in the Declaration of Helsinki and ethically approved by the Ethical Committee of the Medical Faculty of the University of Würzburg. Primary human T cells were enriched from peripheral blood

obtained from healthy Ponatinib donors by Ficoll gradient centrifugation followed on nylon wool columns and maintained in RPMI1640/10% FBS. Immature DC (iDC) were generated from monocytes in RPMI 1640/5% FBS by culture with GM-CSF (500 U/mL; Strathmann) and 250 U/mL IL-4 (250 U/mL; Promocell) and, when indicated, exposed to LPS (100 ng/mL) (LPS-DC) or a mock preparation obtained by freeze/thawing and subsequent low-speed centrifugation of human lymphoblastoid BJAB cells (kept in RPMI1640/10% FBS)(mock-DC) for 24 h. The MV WT strain WTF and the MVrecombinant MGV (expressing VSV-G protein instead of the MV gps 53) were grown on human lymphoblastoid BJAB cells and titrated on marmoset lymphoblastoid B95a cells (kept in RPMI1640/10% FBS). For exposure experiments, MV was purified by sucrose gradient ultracentrifugation as was the mock control from uninfected BJAB cells. T cells were co-cultured with MV (at a multiplicity of infection (m.o.i.) of 0.